David Abramson, Ph.D. - Publications

Affiliations: 
2008 Georgia Institute of Technology, Atlanta, GA 
Area:
Electronics and Electrical Engineering

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kocharian G, Gobin YP, Kharas N, Knopman J, Francis JH, Abramson DH. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution. Journal of Neurointerventional Surgery. PMID 37197934 DOI: 10.1136/jnis-2023-020109  0.313
2021 Abramson DH, Gobin YP, Francis JH. Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy. Ophthalmology. 128: 1437. PMID 34556310 DOI: 10.1016/j.ophtha.2021.03.018  0.301
2019 Farouk Sait S, Haque S, Karimi S, Rebeiz KJ, Francis JH, Marr BP, Abramson DH, Souweidane MM, Dunkel IJ. A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma. Journal of Pediatric Hematology/Oncology. PMID 31259824 DOI: 10.1097/MPH.0000000000001523  0.449
2019 Gupta MP, Yonekawa Y, Campbell JP, Rusu I, Zahid S, Patel SN, Chau F, Jonas KE, Oltra E, Orlin A, Chang J, Horowitz J, Abramson DH, Marr B, Capone A, et al. Early Diagnosis and Management of Aggressive Posterior Vitreoretinopathy Presenting in Premature Neonates. Ophthalmic Surgery, Lasers & Imaging Retina. 50: 201-207. PMID 30998240 DOI: 10.3928/23258160-20190401-01  0.476
2018 Francis JH, Slakter JS, Abramson DH, Odrich SA, Gobin YP. Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab. American Journal of Ophthalmology Case Reports. 11: 49-51. PMID 29978140 DOI: 10.1016/j.ajoc.2018.05.007  0.302
2018 Bohm KJ, Gobin YP, Francis JH, McInerney G, Dabo-Trubelja A, Dalecki PH, Marr BP, Abramson DH. Choroidal infarction following ophthalmic artery chemotherapy. International Journal of Retina and Vitreous. 4: 16. PMID 29736261 DOI: 10.1186/s40942-018-0119-x  0.532
2018 Rowlands MA, Mondesire-Crump I, Levin A, Mauguen A, Francis JH, Dunkel IJ, Brodie SE, Gobin YP, Abramson DH. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery. Plos One. 13: e0195395. PMID 29698399 DOI: 10.1371/journal.pone.0195395  0.31
2018 Francis JH, Grossniklaus HE, Habib LA, Marr B, Abramson DH, Busam KJ. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi. Investigative Ophthalmology & Visual Science. 59: 117-121. PMID 29332123 DOI: 10.1167/iovs.17-22517  0.436
2017 Boddu SR, Abramson DH, Marr BP, Francis JH, Gobin YP. Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study. Journal of Neurointerventional Surgery. 9: 1107-1112. PMID 29030462 DOI: 10.1136/neurintsurg-2016-012758  0.498
2017 Francis JH, Iyer S, Gobin YP, Brodie SE, Abramson DH. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy. Ophthalmology. PMID 28545735 DOI: 10.1016/j.ophtha.2017.04.010  0.301
2017 Tendler I, Pulitzer MP, Roggli V, Abramson DH, Marr BP. Ocular Argyrosis Mimicking Conjunctival Melanoma. Cornea. PMID 28399037 DOI: 10.1097/ICO.0000000000001191  0.493
2017 Abramson DH, Fabius AW, Francis JH, Marr BP, Dunkel IJ, Brodie SE, Escuder A, Gobin YP. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Ophthalmic Genetics. 1-6. PMID 28095092 DOI: 10.1080/13816810.2016.1244695  0.561
2017 Karl MD, Francis JH, Iyer S, Marr B, Abramson DH. Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding. Journal of Pediatric Ophthalmology and Strabismus. 1-6. PMID 28092395 DOI: 10.3928/01913913-20161116-01  0.474
2017 Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Ophthalmology. PMID 28089679 DOI: 10.1016/j.ophtha.2016.12.015  0.504
2017 Friedman DN, Chou JF, Ford J, Francis J, Sklar CA, Li Y, McCabe MS, Robison LL, Kleinerman R, Marr B, Abramson DH, Oeffinger KC, Dunkel IJ. Visual functioning in adult survivors of retinoblastoma. Journal of Clinical Oncology. 35: 122-122. DOI: 10.1200/Jco.2017.35.5_Suppl.122  0.49
2016 Atkinson TM, Hay JL, Shoushtari A, Li Y, Paucar DJ, Smith SC, Kudchadkar RR, Doyle A, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Linette GP, Gajewski TF, Lutzky J, ... ... Abramson DH, et al. Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma. Journal of Cancer Research and Clinical Oncology. PMID 27921276 DOI: 10.1007/s00432-016-2318-x  0.446
2016 Abdelhakim AH, Francis JH, Marr BP, Gobin YP, Abramson DH, Brodie SE. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function. The British Journal of Ophthalmology. PMID 27539090 DOI: 10.1136/bjophthalmol-2016-308591  0.539
2016 Abramson DH, Marr BP, Francis JH. Intra-arterial Chemotherapy for Retinoblastoma. Jama Ophthalmology. PMID 27533893 DOI: 10.1001/jamaophthalmol.2016.2714  0.575
2016 Abramson DH, Marr BP, Francis JH, Dunkel IJ, Fabius AW, Brodie SE, Mondesire-Crump I, Gobin YP. Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy). Plos One. 11: e0156806. PMID 27258771 DOI: 10.1371/journal.pone.0156806  0.554
2016 Francis JH, Wiesner T, Milman T, Won HH, Lin A, Lee V, Albert DM, Folberg R, Berger MF, Char DH, Marr B, Abramson DH. Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic Melanocytomas. Ocular Oncology and Pathology. 2: 171-7. PMID 27239460 DOI: 10.1159/000442352  0.428
2016 Francis JH, Marr BP, Abramson DH. Classification of Vitreous Seeds in Retinoblastoma: Correlations with Patient, Tumor, and Treatment Characteristics. Ophthalmology. PMID 27030103 DOI: 10.1016/j.ophtha.2016.02.036  0.513
2016 Abramson DH, Daniels AB, Marr BP, Francis JH, Brodie SE, Dunkel IJ, Gobin YP. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma. Plos One. 11: e0146582. PMID 26756643 DOI: 10.1371/journal.pone.0146582  0.548
2016 Friedman DN, Chou JF, Oeffinger KC, Kleinerman RA, Ford JS, Sklar CA, Li Y, McCabe MS, Robison LL, Marr BP, Abramson DH, Dunkel IJ. Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study. Cancer. PMID 26755259 DOI: 10.1002/Cncr.29704  0.426
2016 Francis JH, Mondesire-Crump I, Marr BP, Brodie SE, Abramson DH. Cytopathological evaluation of ocular surface and needle washings following intravitreal melphalan injections for retinoblastoma Journal of Pediatric Ophthalmology and Strabismus. 53: 96-98. DOI: 10.3928/01913913-20160311-01  0.482
2015 Abramson DH, Fabius AW, Issa R, Francis JH, Marr BP, Dunkel IJ, Gobin YP. Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC. Plos One. 10: e0145436. PMID 26709699 DOI: 10.1371/journal.pone.0145436  0.549
2015 Francis JH, Marr BP, Brodie SE, Gobin P, Dunkel IJ, Abramson DH. INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA. Retinal Cases & Brief Reports. PMID 26630243 DOI: 10.1097/ICB.0000000000000262  0.508
2015 Tendler I, Belinsky I, Abramson DH, Marr BP. Primary Extradural Ectopic Orbital Meningioma. Ophthalmic Plastic and Reconstructive Surgery. PMID 26505235 DOI: 10.1097/IOP.0000000000000578  0.481
2015 Ford JS, Chou JF, Sklar CA, Oeffinger KC, Novetsky Friedman D, McCabe M, Robison LL, Kleinerman RA, Li Y, Marr BP, Abramson DH, Dunkel IJ. Psychosocial Outcomes in Adult Survivors of Retinoblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26417002 DOI: 10.1200/Jco.2014.60.5733  0.443
2015 Francis JH, Marr BP, Brodie SE, Abramson DH. Anterior Ocular Toxicity of Intravitreous Melphalan for Retinoblastoma. Jama Ophthalmology. 1-5. PMID 26378741 DOI: 10.1001/jamaophthalmol.2015.3119  0.516
2015 Yannuzzi NA, Francis JH, Marr BP, Belinsky I, Dunkel IJ, Gobin YP, Abramson DH. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis. Jama Ophthalmology. 133: 1062-6. PMID 26181236 DOI: 10.1001/jamaophthalmol.2015.2243  0.587
2015 Ediriwickrema LS, Francis JH, Arslan-Carlon V, Dalecki PH, Brodie SE, Marr BP, Abramson DH. Intravenous injection of indocyanine green results in an artificial transient desaturation by pulse oximetry. Retinal Cases & Brief Reports. 9: 252-5. PMID 26002141 DOI: 10.1097/ICB.0000000000000152  0.501
2015 Francis JH, Marr BP, Schaiquevich P, Kellick MG, Abramson DH. Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma. The British Journal of Ophthalmology. 99: 1320-2. PMID 25926516 DOI: 10.1136/bjophthalmol-2015-306633  0.461
2015 Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier FL. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan. Ophthalmology. 122: 1173-9. PMID 25795478 DOI: 10.1016/j.ophtha.2015.01.017  0.444
2015 Francis JH, Abramson DH, Gobin YP, Marr BP, Tendler I, Brodie SE, Dunkel IJ. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma. Ophthalmology. 122: 1016-22. PMID 25616769 DOI: 10.1016/j.ophtha.2014.11.029  0.565
2015 Marr BP, Abramson DH, Cohen GN, Williamson MJ, McCormick B, Barker CA. Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity. Jama Ophthalmology. 133: 283-9. PMID 25502420 DOI: 10.1001/jamaophthalmol.2014.5079  0.495
2015 Boddu S, Abramson D, Marr B, Francis J, Gobin P. P-018 selective intraarterial chemotherapy for retinoblastoma: fluoroscopic time and radiation dose parameters - a baseline study Journal of Neurointerventional Surgery. 7: A31.2-A32. DOI: 10.1136/neurintsurg-2015-011917.57  0.454
2015 Gobin Y, Francis J, Marr B, Brodie S, Dunkel I, Abramson D. E-043 complications of intra-arterial chemotherapy (chemosurgery) for retinoblastoma Journal of Neurointerventional Surgery. 7: A61.2-A62. DOI: 10.1136/neurintsurg-2015-011917.118  0.546
2014 Dunkel IJ, Shi W, Salvaggio K, Marr BP, Brodie SE, Gobin YP, Abramson DH. Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastoma. Plos One. 9: e108692. PMID 25303673 DOI: 10.1371/journal.pone.0108692  0.553
2014 Francis JH, Marr BP, Brodie SE, Gobin YP, Abramson DH. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma. Jama Ophthalmology. 132: 1024-5. PMID 25124953 DOI: 10.1001/jamaophthalmol.2014.436  0.462
2014 Liu CY, Francis JH, Brodie SE, Marr B, Pulido JS, Marmor MF, Abramson DH. Retinal toxicities of cancer therapy drugs: biologics, small molecule inhibitors, and chemotherapies. Retina (Philadelphia, Pa.). 34: 1261-80. PMID 24949716 DOI: 10.1097/IAE.0000000000000242  0.484
2014 Francis JH, Xu XL, Gobin YP, Marr BP, Brodie SE, Abramson DH. Death by water: precautionary water submersion for intravitreal injection of retinoblastoma eyes. The Open Ophthalmology Journal. 8: 7-11. PMID 24949111 DOI: 10.2174/1874364101408010007  0.483
2014 Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, ... ... Abramson DH, et al. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. Jama. 311: 2397-405. PMID 24938562 DOI: 10.1001/Jama.2014.6096  0.47
2014 Barker CA, Francis JH, Cohen GN, Marr BP, Wolden SL, McCormick B, Abramson DH. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence. Brachytherapy. 13: 584-90. PMID 24880583 DOI: 10.1016/j.brachy.2014.04.002  0.499
2014 Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada GL, Abramson DH. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 121: 1810-7. PMID 24819859 DOI: 10.1016/j.ophtha.2014.03.028  0.506
2014 Klein KA, Francis J, Abramson DH, Marr B, Dalecki P. Re: "lymphatic drainage patterns of the human eyelid: assessed by lymphscintography". Ophthalmic Plastic and Reconstructive Surgery. 30: 191-3. PMID 24614554 DOI: 10.1097/IOP.0000000000000049  0.422
2014 Francis JH, Abramson DH, Gobin YP, Marr BP, Dunkel IJ, Riedel ER, Brodie SE. Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review. Plos One. 9: e84247. PMID 24465398 DOI: 10.1371/journal.pone.0084247  0.583
2014 Friedman DN, Lis E, Sklar CA, Oeffinger KC, Reppucci M, Fleischut MH, Francis JH, Marr B, Abramson DH, Dunkel IJ. Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study. Pediatric Blood & Cancer. 61: 1440-4. PMID 24402721 DOI: 10.1002/pbc.24835  0.433
2014 Liu CY, Jonna G, Francis JH, Marr BP, Abramson DH, Brodie SE. Non-selectivity of ERG reductions in eyes treated for retinoblastoma. Documenta Ophthalmologica. Advances in Ophthalmology. 128: 13-23. PMID 24213436 DOI: 10.1007/s10633-013-9416-8  0.56
2014 Barker C, Francis J, Cohen G, Marr B, Wolden S, McCormick B, Abramson D. Ruthenium-106 Plaque Brachytherapy for Uveal Melanoma: Factors Associated With Local Tumor Recurrence International Journal of Radiation Oncology*Biology*Physics. 90: S304. DOI: 10.1016/j.ijrobp.2014.05.1018  0.468
2013 Abramson DH, Dunkel IJ, Marr BP, Francis J, Gobin YP. Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. American Journal of Ophthalmology. 156: 1319-20. PMID 24238207 DOI: 10.1016/j.ajo.2013.09.005  0.442
2013 Schefler AC, Gologorsky D, Marr BP, Shields CL, Zeolite I, Abramson DH. Extraocular extension of uveal melanoma after fine-needle aspiration, vitrectomy, and open biopsy. Jama Ophthalmology. 131: 1220-4. PMID 24030334 DOI: 10.1001/jamaophthalmol.2013.2506  0.479
2013 Francis JH, Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Jonna G, Abramson DH. Carboplatin +/- topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma. Plos One. 8: e72441. PMID 23991112 DOI: 10.1371/journal.pone.0072441  0.597
2013 Francis JH, Barker CA, Wolden SL, McCormick B, Segal K, Cohen G, Gobin YP, Marr BP, Brodie SE, Dunkel IJ, Abramson DH. Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma. International Journal of Radiation Oncology, Biology, Physics. 87: 517-23. PMID 23953635 DOI: 10.1016/j.ijrobp.2013.06.2045  0.576
2013 Francis JH, Abramson DH, Marr BP, Brodie SE. Ocular manipulation reduces both ipsilateral and contralateral electroretinograms. Documenta Ophthalmologica. Advances in Ophthalmology. 127: 113-22. PMID 23733194 DOI: 10.1007/s10633-013-9391-0  0.492
2013 Mahida JP, Antczak C, Decarlo D, Champ KG, Francis JH, Marr B, Polans AS, Albert DM, Abramson DH, Djaballah H. A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma. Plos One. 8: e59156. PMID 23527118 DOI: 10.1371/Journal.Pone.0059156  0.474
2013 Abramson DH, Francis JH, Dunkel IJ, Marr BP, Brodie SE, Gobin YP. Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors. Ophthalmology. 120: 560-5. PMID 23177361 DOI: 10.1016/j.ophtha.2012.08.023  0.544
2013 Francis JH, Abramson DH, Brodie SE, Marr BP. Indocyanine green enhanced transpupillary thermotherapy in combination with ophthalmic artery chemosurgery for retinoblastoma. The British Journal of Ophthalmology. 97: 164-8. PMID 23143908 DOI: 10.1136/bjophthalmol-2012-302495  0.558
2013 Brodie SE, Munier FL, Francis JH, Marr B, Gobin YP, Abramson DH. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma. Documenta Ophthalmologica. Advances in Ophthalmology. 126: 79-84. PMID 23143758 DOI: 10.1007/s10633-012-9358-6  0.509
2013 Friedman DN, Sklar CA, Oeffinger KC, Kernan NA, Khakoo Y, Marr BP, Wolden SL, Abramson DH, Dunkel IJ. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Pediatric Blood & Cancer. 60: 694-9. PMID 22911631 DOI: 10.1002/pbc.24280  0.448
2012 Abramson DH, Marr BP, Brodie S, Dunkel IJ, Gobin PY. Intraarterial chemotherapy for kissing macula tumors in retinoblastoma. Retinal Cases & Brief Reports. 6: 209-11. PMID 25390966 DOI: 10.1097/ICB.0b013e318234ccf4  0.484
2012 Francis JH, Gobin YP, Nagiel A, Dunkel IJ, Kucine N, Marr BP, Brodie SE, Abramson DH. Thrombophilia in patients with retinoblastoma receiving ophthalmic artery chemosurgery. Archives of Ophthalmology (Chicago, Ill. : 1960). 130: 1605-8. PMID 23229706 DOI: 10.1001/archophthalmol.2012.2284  0.551
2012 Gobin YP, Dunkel IJ, Marr BP, Francis JH, Brodie SE, Abramson DH. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma. Plos One. 7: e44322. PMID 23028521 DOI: 10.1371/journal.pone.0044322  0.532
2012 Marr BP, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH. Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results. The British Journal of Ophthalmology. 96: 1300-3. PMID 22863945 DOI: 10.1136/bjophthalmol-2012-301925  0.577
2012 Abramson DH, Gobin YP, Marr BP, Dunkel IJ, Brodie SE. Intra-arterial chemotherapy for retinoblastoma. Ophthalmology. 119: 1720-1; author reply. PMID 22858038 DOI: 10.1016/j.ophtha.2012.03.039  0.575
2012 Francis JH, Gobin YP, Brodie SE, Marr BP, Dunkel IJ, Abramson DH. Experience of intra-arterial chemosurgery with single agent carboplatin for retinoblastoma. The British Journal of Ophthalmology. 96: 1270-1. PMID 22611138 DOI: 10.1136/bjophthalmol-2012-301686  0.532
2012 Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. Plos One. 7: e34120. PMID 22545080 DOI: 10.1371/journal.pone.0034120  0.558
2012 Palioura S, Gobin YP, Brodie SE, Marr BP, Dunkel IJ, Abramson DH. Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment. Pediatric Blood & Cancer. 59: 859-64. PMID 22492689 DOI: 10.1002/pbc.24170  0.591
2012 Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: Alternatives to direct ophthalmic artery catheterization American Journal of Neuroradiology. 33: 1608-1614. PMID 22442047 DOI: 10.3174/ajnr.A3019  0.579
2012 Brodie SE, Paulus YM, Patel M, Gobin YP, Dunkel IJ, Marr BP, Abramson DH. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma. The British Journal of Ophthalmology. 96: 877-80. PMID 22426950 DOI: 10.1136/bjophthalmol-2011-301248  0.549
2012 Gobin YP, Rosenstein LM, Marr BP, Brodie SE, Abramson DH. Radiation exposure during intra-arterial chemotherapy for retinoblastoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 130: 403-4; author reply . PMID 22411679 DOI: 10.1001/archopthalmol.2011.2717  0.525
2012 Marr BP, Hung C, Gobin YP, Dunkel IJ, Brodie SE, Abramson DH. Success of intra-arterial chemotherapy (chemosurgery) for retinoblastoma: effect of orbitovascular anatomy. Archives of Ophthalmology (Chicago, Ill. : 1960). 130: 180-5. PMID 22332209 DOI: 10.1001/archophthalmol.2011.386  0.575
2012 Marr BP, Dunkel IJ, Linker A, Abramson DH. Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity. The British Journal of Ophthalmology. 96: 881-3. PMID 22328819 DOI: 10.1136/bjophthalmol-2011-300517  0.495
2012 Abramson DH, Marr BP, Brodie SE, Dunkel IJ, Lin A, Folberg R, Gobin YP. Intraocular hemorrhage after intra-arterial chemotherapy for retinoblastoma in sickle cell trait. The Open Ophthalmology Journal. 6: 1-3. PMID 22291865 DOI: 10.2174/1874364101206010001  0.524
2012 Gobin YP, Marr BP, Dunkel IJ, Abramson DH, Brodie SE. Retinoblastoma. Journal of Neurosurgery. 116: 470-2; author reply . PMID 22117180 DOI: 10.3171/2011.2.JNS11306  0.491
2012 Abramson DH, Marr BP, Dunkel IJ, Brodie S, Zabor EC, Driscoll SJ, Gobin YP. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. The British Journal of Ophthalmology. 96: 499-502. PMID 22053101 DOI: 10.1136/bjophthalmol-2011-300498  0.588
2012 Carvajal RD, Ambrosini G, Wolchok JD, Chapman PB, Dickson MA, D'Angelo SP, Bluth MJ, Paucar D, Fusco A, Bohr D, Roman RA, Montefusco M, Doyle LA, Marr B, Abramson DH, et al. Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma. Journal of Clinical Oncology. 30: 8598-8598. DOI: 10.1200/Jco.2012.30.15_Suppl.8598  0.476
2011 El-Sawy T, He L, Chiang MF, Anyane-Yeboa K, Morel KD, Folberg R, Marr BP, Abramson D. Retinoblastoma presenting in a child with hypomelanosis of Ito. The Open Ophthalmology Journal. 5: 55-8. PMID 22216075 DOI: 10.2174/1874364101105010055  0.443
2011 Patel M, Winston CB, Marr BP, Carvajal RD, Schwartz GK, Wolchok J, Busam K, Abramson DH. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 129: 1576-82. PMID 22159677 DOI: 10.1001/Archophthalmol.2011.263  0.458
2011 Abramson DH, Gobin YP, Dunkel I, Marr BP, Brodie S, Freund KB. Highlighting complications over successes in occurrence of sectoral choroidal occlusive vasculopathy. Retina (Philadelphia, Pa.). 31: 1746; author reply 1. PMID 21826040 DOI: 10.1097/IAE.0b013e31822650ab  0.482
2011 Patel M, Paulus YM, Gobin YP, Djaballah H, Marr B, Dunkel IJ, Brodie S, Antczak C, Folberg R, Abramson DH. Intra-arterial and oral digoxin therapy for retinoblastoma. Ophthalmic Genetics. 32: 147-50. PMID 21446853 DOI: 10.3109/13816810.2010.544530  0.51
2011 Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, Bornfeld N, Char DH, Folberg R, Imhof SM, Lin AY, Berry JL, Al Mesfer S, Moll AC, Abramson DH. Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. The Open Ophthalmology Journal. 5: 1-5. PMID 21399766 DOI: 10.2174/1874364101105010001  0.546
2011 Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Archives of Ophthalmology (Chicago, Ill. : 1960). 129: 732-7. PMID 21320950 DOI: 10.1001/archophthalmol.2011.5  0.572
2011 Patel M, McNally L, Marr BP, McCormick SA, Abramson DH. Primary melanoma of the optic nerve in a patient with 16-year follow up. Ophthalmic Plastic and Reconstructive Surgery. 27: e69-71. PMID 20871468 DOI: 10.1097/IOP.0b013e3181e9a043  0.476
2011 Marr B, Gobin PY, Dunkel IJ, Brodie SE, Abramson DH. Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma. Middle East African Journal of Ophthalmology. 17: 207-9. PMID 20844675 DOI: 10.4103/0974-9233.65492  0.578
2010 Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery) Ophthalmology. 117: 1623-1629. PMID 20381868 DOI: 10.1016/j.ophtha.2009.12.030  0.601
2010 Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: Tandem therapy Archives of Ophthalmology. 128: 370-372. PMID 20212212 DOI: 10.1001/archophthalmol.2010.7  0.564
2010 Feinstein EG, Marr BP, Winston CB, Abramson DH. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma Archives of Ophthalmology. 128: 319-323. PMID 20212202 DOI: 10.1001/archophthalmol.2009.401  0.468
2010 Busam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization Journal of Cutaneous Pathology. 37: 196-203. PMID 20100177 DOI: 10.1111/j.1600-0560.2009.01488.x  0.457
2009 Maki JL, Marr BP, Abramson DH. Diagnosis of retinoblastoma: how good are referring physicians? Ophthalmic Genetics. 30: 199-205. PMID 19852578 DOI: 10.3109/13816810903258837  0.44
2009 Gobin P, Marr B, Dunkel I, Brodie S, Abramson D. 014 Intra-arterial chemotherapy (chemosurgery) in the ophthalmic artery for the treatment of retinoblastoma in children: 3 year experience Journal of Neurointerventional Surgery. 1: 77-78. DOI: 10.1136/jnis.2009.000851n  0.57
Show low-probability matches.